Board of Directors
  • Cem Öztürk (Chairman) – Sanofi
  • Şehram Zayer (Vice Chair) – Merck
  • Okan Güner (Vice Chair) – Boehringer Ingelheim
  • Cenk Balcı (Treasurer) – Menarini
  • Ece Kaşıkçı – BMS
  • Metin Hullu – Pfizer
  • Serkan Barış – Novartis
  • Farid Bidgoli – Roche
  • Alban Nerot – Servier
  • Murat Oymak- Organon
  • Bike Başaklar – Novo Nordisk
High Advisory Board
  • Colin John Tyrer – Bayer
  • Münevver Gönenç – AstraZeneca
  • İsmet İnce – Inpharmus
  • Barlas Döner – AbbVie
  • Jorge Arevalo – GSK
  • Ryan Edward Dawson – Lilly
Board of Auditors
  • Muhittin Bilgütay (Chairman) – Bausch+Lomb
  • Dr. Emre Kara – Chiesi
  • Derya Köker – Alexion
Secretariat
  • Dr. Ümit Dereli (Secretary General)
  • Canan Tütüncü (Executive Assistant to the Secretary General)
  • Dr. Ecz. Nihan Burul Bozkurt (Deputy Secretary General)
  • Gülgün Günaydın (Complaince ve HR Coordinator)
  • Meral Yücel (Senior Administrative Affairs Manager)
  • Sevda Ceyhan (Senior Manager, Government Affairs & Health Economic Policies)
  • Gökhan Özkan (Senior Health Policies Manager)
  • Şule Yüksel (Corporate Communications and Patient Initiative Manager)
  • Eralp Erçetin (Economic Policies Specialist)
  • Furkan Kaya (Health Policies Assistant Specialist)
  • Özlem Taştan (Office Person)
Strategic Management Committees (SMC)
  • Ethics & Compliance SMC
  • Health Economic Policies SMC
  • Health Science Policies SMC
Steering Committee
  • Corporate Communications and Advocacy Steering Committee
  • Patient Initiatives Steering Committee
Task Forces
  • Price Task Force
  • Reimbursement Task Force
  • Regulatory Task Force
  • Advanced Therapy Medicinal Products Task Force
  • Clinical Trials Task Force